Long-Term Management Of Cll For Improved Outcomes

Long-term management of CLL for improved outcomes

VJHemOnc – Video Journal of Hematology & HemOnc

Managing CLL as a chronic disease in the long term to improve overall outcome

VJHemOnc – Video Journal of Hematology & HemOnc

Improving the long-term safety of CLL treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term outcomes and toxicities of ibrutinib in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term outcomes of patients with CLL treated with continuous ibrutinib

VJHemOnc – Video Journal of Hematology & HemOnc

The future of CLL treatment: aiming for long-lasting remission

VJHemOnc – Video Journal of Hematology & HemOnc

Towards strategies to optimize outcomes in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Fixed duration treatment strategies in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Impact of novel treatment options on long-term outcomes in CLL and WM

Impacting CLL Management With Lifestyle Modification

Further Improving the Management of CLL

Targeted Oncology

How to Make Confident and Informed CLL Treatment Decisions

Patient Empowerment Network

How Long Can I Live with CLL? (Chronic Lymphocytic Leukemia) | The Patient Story

The Patient Story

Long-term outcomes of the iFCG regimen for firstline treatment of patients with IGHV-mutated CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Jones on Long-Term Outcomes With Ibrutinib in CLL

CLL: Long-term updates on ibrutinib and idelalisib

Improving patient outcomes and extending survival in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Sequencing of therapies to improve outcomes of CLL patients

VJHemOnc – Video Journal of Hematology & HemOnc

Living with Leukemia: The LATEST Treatment Options in Chronic Lymphocytic Leukemia|The Patient Story

The Patient Story

Claire Dearden - Understanding CLL – How to treat in 2016 and beyond

CLL Support Association (CLLSA)